Methods, devices and formulations for targeted endobronchial therapy
View Patent ↗The present invention provides an improved means of treating tracheobronchitis, bronchiectasis and pneumonia in the nosocomial patient, preferably with aerosolized anti gram-positive and anti-gram negative antibiotics administered in combination or in seriatim in reliably sufficient amounts for therapeutic effect. In one aspect, the invention assures this result when aerosol is delivered into the ventilator circuit. In one embodiment the result is achieved mechanically. In another embodiment, the result is achieved by aerosol formulation. In another aspect, the invention assures the result when aerosol is delivered directly to the airways distal of the ventilator circuit. The treatment means eliminates the dosage variability that ventilator systems engender when aerosols are introduced via the ventilator circuit. The treatment means also concentrates the therapeutic agent specifically at affected sites in the lung such that therapeutic levels of administrated drug are achieved without significant systemic exposure of the patient to the drug. The invention further provides a dose control device to govern this specialized regimen.
1. A method, comprising:
a) providing:
i) a patient, said patient intubated with a tube selected from endotracheal tubes and tracheostomy tubes, said tube having a lower end and an upper end;
ii) a formulation comprising a first antibiotic;
iii) an aerosol delivery device comprising an upper end and a lower end, said lower end comprising an aerosol delivery end configured to fit within said patient's trachea;
b) inserting said aerosol delivery end of said device within said patient's trachea to create a positioned device; and
c) aerosolizing said formulation under conditions such that said formulation is delivered through said aerosol delivery end of said positioned device to said patient, wherein said aerosol first contacts said trachea.
2. The method of claim 1 , wherein said aerosol delivery device comprises an aerosol delivery catheter.
3. The method of claim 1 , wherein said aerosol delivery device comprises a bronchoscope fitted with an aerosolizing nozzle.
4. The method of claim 1 , wherein said aerosol delivery device comprises a metered dose inhaler fitted with a nozzle extension.
5. The method of claim 1 , wherein said formulation further comprises a second antibiotic, wherein said first antibiotic has activity against gram positive bacteria and said second antibiotic has activity against gram negative bacteria.
6. A method, comprising:
a) providing:
i) a patient exhibiting an elevated white blood cell count;
ii) a formulation comprising a first antibiotic having activity against gram positive bacteria and a second antibiotic having activity against gram negative bacteria;
iii) a aerosol delivery device comprising an upper end and a lower end, said lower end comprising an aerosol delivery end configured to fit within said patient's trachea;
b) inserting said aerosol delivery end of said device within said patient's trachea to create a positioned device; and
c) aerosolizing said formulation under conditions such that said formulation is delivered through said aerosol delivery end of said positioned device to said patient to create a treated patient, wherein said aerosol first contacts said trachea.
7. The method of claim 6 , wherein said aerosol delivery device comprises an aerosol delivery catheter.
8. The method of claim 6 , further comprising d) measuring the white blood cell count of said treated patient after step (c).